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A B S T R A C T
Leptospirosis is known as a zoonotic disease of global importance originated from infection with the spirochete
bacterium Leptospira. Although several leptospirosis vaccines have been tested, the vaccination is relatively
unsuccessful in clinical application despite decades of research. Therefore, this study was conducted to construct
a novel multi-epitope based vaccine against leptospirosis by using Hap1, LigA, LAg42, SphH and HSP58 anti-
gens. T cell and IFN gamma epitopes were predicted from these antigens. In addition, to induce strong CD4+
helper T lymphocytes (HTLs) responses, Pan HLA DR-binding epitope (PADRE) and helper epitopes selected
from Tetanus toxin fragment C (TTFrC) were applied. Moreover, for boosting immune response, Heparin-Binding
Hemagglutinin (HBHA), a novel TLR4 agonist was added to the construct as an adjuvant. Finally, selected
epitopes were linked together using EAAAK, GPGPG, AAY and HEYGAEALERAG linkers. Based on the predicted
epitopes, a multi-epitope vaccine was construct with 490 amino acids. Physico-chemical properties, secondary
and tertiary structures, stability, intrinsic protein disorder, solubility, and allergenicity of this vaccine construct
were assessed by applying immunoinformatics analyses. A soluble, and non-allergic protein with a molecular
weight of 53.476 kDa was obtained. Further analyses validated the stability of the chimeric protein and the
predicted epitopes in the chimeric vaccine indicated strong potential to induce B-cell and T-cell mediated im-
mune response. Therefore, immunoinformatics analysis showed that the modeled multi-epitope vaccine can
properly stimulate the both T and B cells immune responses and could potentially be used for prophylactic or
therapeutic usages.
1. Introduction
Leptospirosis is known as a zoonotic disease of global importance
originated from infection with the spirochete bacterium Leptospira
(Vinetz, 2001). Leptospires are highly motile, obligate aerobic spir-
ochetes that mimic features of both gram-positive and gram-negative
bacteria (Palaniappan et al., 2007). Leptospires are about 0.25× 6
−25 μm in size and can easily pass through 0.45 μM ﬁlters. The ge-
netically based classiﬁcation of Leptospira indicates that there are at
least 19 species that seven of these species were introduaced as main
causes of leptospirosis including L. interrogans, L. borgpetersenii, L.
santarosai, L. noguchii, L. weilli, L. kirschneri and L. alexanderi
(Evangelista and Coburn, 2010). Leptospirosis was ﬁrstly presented as
Weil's syndrome (Adler et al., 2010). Leptospirosis has a worldwide
distribution and has also emerged as a disease of the adventure
traveller, especially aﬀecting humans who are frequently in contact
with rodents, pets or polluted water (Trueba et al., 2004; Waitkins,
1986). This spiral-shaped bacterium can the ability of penetrating the
mucosa or an open skin. After penetrating, the bacterium can lead to
serious clinical manifestation (Schmid et al., 1986). These clinical
presentations comprise hepatitis, nephritis, meningitis, pneumonitis,
and pancreatitis and ultimately death (Christova et al., 2003; Katz et al.,
2001). The interaction of leptospires with pathogen recognition re-
ceptors is a major issue in immune responses against Leptospira and in
immunopathology (Fraga et al., 2011). Pathogenic leptospires are able
to evade the host immune system, circulate in the blood and spread into
tissues. The rapid dissemination of pathogenic leptospires to kidney ﬁ-
broblasts lead to induction of apoptosis or programmed cell death and
result in renal failure (Merien et al., 1997). Therefore, inadequate
function of immune response against pathogenic leptospires is a new
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challenge to develop an eﬀective approach to reinforce immune system
responses against leptospirosis. Recently, molecular and cellular studies
on leptospirosis have been focused on the ﬁeld of leptospirosis vaccines
(Adler, 2015). Although vaccines to prevent human leptospirosis are
available in some countries, several problems confront the development
of a vaccine to prevent human leptospirosis including an unacceptable
side eﬀect proﬁle of killed bacterial vaccines, short-term and in-
complete protection of killed bacteria vaccines, the locally varying
patterns of Leptospira, theoretical potential for inducing autoimmune
disease such as uveitis and, ﬁnally an incomplete knowledge of me-
chanisms of protective immunity against leptospiral infection (Koizumi
and Watanabe, 2005).
To design a Leptospira vaccine, conserved protein components of
diﬀerent serovares of Leptospira are established as ideal targets. Among
vaccine-related genes were founded through the web based VIOLIN
vaccine database and previously experimental studies, hemolysis-asso-
ciated protein-1 (Hap1), leptospiral immunoglobulin (Ig)-like proteins
A (LigA), LAg42, hemolysin SphH and heat-shock protein 58 (HSP58)
were considered as priority antigens for developing a subunit vaccine.
The Hap1 (also known as LipL32) was determined as a protein ex-
pressed in pathogenic Leptospira. The Hap1 was used as an immunogen
through Adenovirus delivery and induced signiﬁcant protection against
a virulent heterologous Leptospira challenge in vaccinated animal
models (Branger et al., 2001). Also DNA vaccines expressing Hap1 have
been shown cross-protective eﬀect with pathogenic strains of Leptospira
(Branger et al., 2005). Hence, it could be a good candidate for develop
of new vaccines. In addition, Lig proteins are a fraction of leptospiral
surface components that binds to extracellular matrix (ECM). There-
fore, these proteins may be involved in bacterial attachment to host
tissues and facilitate the bacterial colonization process. LigA contains a
lipoprotein signal peptide that followed by 12–13 series of Ig-like do-
mains. The ﬁrst six domains of LigA along with a portion of the seventh
domain are 99% identical with LigB (Lin et al., 2009; Lin et al., 2010).
Currently, several studies have shown that LigA subunit or DNA vac-
cines generated from diﬀerent serovars could induce protective immune
responses in rodent models and protected them from homologous
challenge infection (Koizumi and Watanabe, 2004; Palaniappan et al.,
2006; Silva et al., 2007). The novel antigen LAg42 was ﬁrst introduced
by Koizumi and et al. The LAg42 gene was conserved among various
pathogenic strains of Leptospira but not among non-pathogenic leptos-
pires. The LAg42 is an inner membrane protein with molecular weight
42 kDa that its C-terminal is immunogenic. Also in vivo experiments
suggest that LAg42 may be a good target for protective immune re-
sponse (Koizumi and Watanabe, 2003). Furthermore, it has been shown
that hemolysins are virulence factors for the pathogenesis of leptos-
pirosis. The SphH is a novel Leptospira hemolysin determined among the
pathogenic Leptospira and act as a pore-forming protein. The SphH is
highly conserved among pathogenic leptospires and directly caused
membrane damage of cells that indicated its potential role in patho-
genesis of leptospirosis (Lee et al., 2002). Additionally heat shock
proteins (HSPs) as molecular chaperons are highly conserved molecules
that protect cells from various stimuli and act as major antigens of
various microbial pathogens. They signiﬁcantly induce humoral and
cellular immune responses. In this context, HSP58 antigen is recognized
by antibodies in sera of patients infected with several serovars of lep-
tospires. More in vitro experiments introduced a speciﬁc region of
amino acids in the HSP58 for its immunoreactivity. Hence, it can apply
as an important target for humoral immune responses induction during
leptospirosis (Flannery et al., 2001; S. H. Park et al., 1999). Therefore,
to develop eﬃcient subunit vaccine against leptospirosis, these im-
munogenic proteins were targeted.
Considering recent advances in the ﬁeld of vaccine development
using bioinformatics and immunoinformatics approaches (Karkhah
et al., 2017; Saadi et al., 2017), these problems seems resolvable in the
development of a vaccine to prevent human leptospirosis. Considering
the beneﬁts of multi-epitope vaccines including high immunogenicity,
stability in various conditions, and high speciﬁcity as well as aﬀordable
production, in this study we developed a multi-epitope protein from
immune-dominant peptides of Hap1, LigA, LAg42, SphH and HSP58
antigen with appropriate linkers using bioinformatics tools. Modeling
of protein structure and codon optimization for expression in Escher-
ichia coli was carried out and the potential of the developed vaccine for
inducing the immune responses were evaluated.
2. Materials and methods
2.1. Sequence retrieval and homology analyses
In the ﬁrst step, Uniprot Knowledgebase data was used to retrieve
the amino acid sequences of Hap1 (Accession no. Q79B72), LigA
(Accession no. C7SAC0), LAg42 (Accession no. AB091092), SphH
(Accession no. O34095), HSP58 (Accession no. P61439) antigens, te-
tanus toxin fragment C (Accession no. 1A8D_A), and HBHA of
Mycobacterium tuberculosis (Accession no. ZP_07011362.1) in FASTA
format. L. interrogans was targeted for antigen selection. The selected
antigens may have variation in amino acids sequences between seven
species of Leptospira were responsible for leptospirosis, therefore mul-
tiple sequence alignments (MSA) were performed on deposited se-
quence of selected antigens to assess the conserved regions. The MSA
was performed by CLUSTALW at https://www.genome.jp/tools-bin/
clustalw or National Centre for Biotechnology Information (NCBI) at
http://www.ncbi.nlm.nih/Blast. However, all subsequent analyzes
were performed on conserved sequences.
2.2. T-cell epitopes Prediction
Potential T cell epitopes in Hap1, LigA, LAg42, SphH and HSP58
proteins were predicted by using CTLpred online server (Bhasin and
Raghava, 2004). This server is mainly based on elegant machine
learning techniques such as Vector Machine (SVM) and Artiﬁcial Neural
Network. CTL epitopes were also predicted in consensus and combined
approaches for more speciﬁc and sensitive results.
2.3. Interferon-gamma inducing epitopes prediction
To obtain a vaccine with strong ability of the immune system re-
inforcement, interferon-gamma inducing epitopes were also studied by
using the IFNepitope server at http://crdd.osdd.net/raghava/
ifnepitope/ (Dhanda et al., 2013). This web server works based on a
dataset including IFN-gamma inducing and non-inducing MHC class II
binders through diﬀerent algorithms, such as machine learning tech-
nique, motifs-based search, and hybrid approach.
2.4. MHC binding epitopes predictions
ProPred online server at http://www.imtech.res.in/raghava/
propred/ was used to predict MHC class I- binding peptides. This on-
line server provides quantitative matrices for 47 MHC Class-I alleles.
The maximum accuracy of ProPred server is 75% at default threshold.
Another server IEDB MHC I prediction tool at http://tools.iedb.org/
mhci/nthat was used for the prediction of MHC class I- binding pep-
tides. MHC-II peptide binders were predicted by RANKPEP from protein
sequences at http://bio. dfci.harvard.edu/RANKPEP. This server uti-
lizes position-speciﬁc scoring matrix (PSSM) to predicts peptides.
2.5. Determination of conserved domain
NCBI’s Conserved Domain Database (CDD) was applied to predict
conserved structural and functional amino acid sequences at http://
www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml. This data bank can
identify conserved domains in protein structures using RPS-BLAST.
Moreover, predicted epitopes were subjected for analysis of epitope
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conservancy at http://tools.iedb.org/conservancy/ (Bui et al., 2007).
2.6. Vaccine construct design and chimeric gene optimization
In this stage, Hap1, LigA, LAg42, sphH and HSP58 proteins were
used for selection of potential T cell and interferon-gamma inducing
epitopes. In addition, TTFrC and PADRE were applied as helper epi-
topes. In addition, Heparin-Binding Hemagglutinin (HBHA) a novel
TLR4 agonist was added to the construct as an adjuvant for boosting
immune response. In the next stage, each peptide segment that was
derived from the helper antigens, the main antigens and HBHA protein
was linked to each other by proper amino acid linkers. Diﬀerent fea-
tures of the aforementioned multi-epitope protein were calculated by
diﬀerent online servers. In addition, JCAT server (http://www.jcat.de)
and DNA2 software were used to obtain the DNA sequence of designed
protein by reverse translation and its adaptation to E. coli codon usage
(Grote et al., 2005).
2.7. mRNA secondary structure prediction
Mfold software was applied for prediction of RNA secondary
structure. Mfold software can provide the prediction of true positive
base pairs and the structures with minimum ΔG thermodynamically
(Zuker, 2003).
2.8. Physico-chemical parameters analysis
ProtParam online server (http://us. expasy.org/tools/ protparam)
was used to evaluate physico-chemical parameters including the amino
acid composition, theoretical isoelectric point, molecular weight (MW),
in-vitro and in-vivo half-life, aliphatic index, instability index, extinc-
tion coeﬃcient, grand average of hydropathicity (GRAVY) and the total
number of positive and negative residues (Wilkins et al., 1999).
2.9. Prediction of secondary and tertiary structure
GOR IV and PSIPRED servers were applied for prediction of the
secondary protein structure at http://expasy.org/tools/gor4.html and
http://bioinf.cs.ucl.ac.uk/psipred/, respectively (McGuﬃn et al., 2000;
Sen et al., 2005). The 3D structure was predicted by using the I TASSER
and Phyre2 (Kelley and Sternberg, 2009; Zhang, 2008). The stereo-
chemical validity of the protein structure and possible errors in 3D
models were determined in PROCHECK program by Ramachandran
plot at http://www.ebi.ac.uk/thornton srv/software/PROCHECK
(Lovell et al., 2003; Wiederstein and Sippl, 2007).
2.10. Reﬁnement of the 3D modeled structure
The reﬁnement of modeled structure was performed by applying
GalaxyReﬁne server at http://galaxy.seoklab.org/cgi-bin/submit.cgi?
type=REFINE. Brieﬂy, modeled structure by using Phyre2 was sub-
jected to reﬁne whole protein. GalaxyReﬁne performs repeated struc-
ture perturbation and subsequent overall structural relaxation by mo-
lecular dynamics simulation (H. Park and Seok, 2012).
2.11. Prediction of intrinsic protein disorder
DisEMBL 1.5 at http://dis.embl.de/ and IUPred at http://iupred.
enzim.hu/pred.php were applied to assess intrinsic protein disorder and
unstructured regions within a protein. DisEMBL is a public web server
for predicting disorder in proteins. In addition, DISOPRED3 was used to
predict intrinsic protein disorder and unstructured regions in our con-
structed vaccine (Jones and Cozzetto, 2015).
2.12. Prediction of B-cell epitopes
Two online servers were applied to predict both linear and con-
formational B cells epitopes. Linear B-cell epitopes were predicted by
BCPREDS server at http://ailab.cs.iastate.edu /bcpreds /predict.html
using subsequence kernel, as a novel method, with speciﬁcity of 74.5%
and conformational B cell epitopes were determined from 3D protein
structure using Discotope server at http://www.cbs.dtu.dk/services/
DiscoTope/ (Kringelum et al., 2012; Saha and Raghava, 2006b).
2.13. Evaluation of allergenicity, antigenicity, sequence similarity and
epitope conservancy analysis
In order to determine protein allergenicity with a high accuracy,
based on six diﬀerent approaches, AlgPred web server at http://www.
imtech.res.in/raghava/algpred/ was applied (Saha and Raghava,
2006a). The accuracy of AlgPred server is about 85% at a threshold
-0.4. Antigenicity was also analyzed applying VaxiJen v2.0 server at
http://www.ddg-pharmfac.net/vaxijen/VaxiJen/VaxiJen.html
(Doytchinova and Flower, 2007). Also, for evaluation the proposed
multi-epitope vaccine similarity with the human proteins, ﬁrstly amino
acid sequence of the proposed vaccine was submitted to the Basic Local
Alignment Search Tool (BLAST) in NCBI. After that, the similarity be-
tween the suggested sequences and multi-epitope vaccine was de-
termined by the multiple sequence alignment (MSA) through Clustal
Omega in EMBL-EBI database. In addition, epitope conservancy ana-
lysis was performed at http://tools.iedb.org /conservancy/ to computes
the degree of conservancy of the selected epitopes in proposed vaccine
within protein sequence of the other pathogenic species of Leptospira.
2.14. Prediction of protein solubility
Propensity of protein solubility was predicted by SOLpro server at
http://scratch.proteomics.ics.uci.edu/. SOLpro predicts the propensity
of a protein to be soluble upon overexpression in E. coli using a two-
stage SVM architecture based on multiple representations of the pri-
mary sequence (Magnan et al., 2009).
2.15. Ligand binding site exploration and molecular docking
For protein-protein docking of the HBHA part of the vaccine as a
ligand and the TLR4 as the receptor, ClusPro at http://nrc.bu.edu/
cluster was used. ClusPro represents the ﬁrst fully automated, web-
based program for the computational docking of protein structures.
3. Results
3.1. Primary analysis of the retrieved sequences
In the present study, Hap1, LigA, LAg42, sphH and HSP58 protein
sequences were applied to immunoinformatic analysis to determine
CD8+ CTL, IFN gamma and MHC binder’s epitopes. Furthermore,
TTFrC and PADRE were used for selection of CD4+ helper epitopes.
Since the vaccine needs the strong induction of T cell immune re-
sponses, highly conserved regions of HBHA were used as adjuvant. The
signal sequences were omitted from all constructed structures.
3.2. Prediction of IFN-γ and CTL epitopes
The high score and suitable CTL epitopes were predicted using
CTLpred server from Hap1, LigA, LAg42, sphH and HSP58 protein se-
quences (Tables 1). Five regions were selected from Hap1, LigA, LAg42,
SphH and HSP58 protein sequences which were subjected to in-silico
analysis in order to collect the best immunoreactive epitopes. In addi-
tion, interferon-gamma inducing epitopes were also predicted by using
the IFNepitope server which can predict IFN-gamma inducing and non-
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inducing MHC class II binders.
3.3. Deﬁning MHC-I and MHC-II binding epitopes
High ranked peptide regions for presenting by MHC class I over
several alleles (MHC-2Kb, MHC-2Dd, MHC-2Kd, MHC-2Kk and MHC-
2Ld) were predicted by applying ProPred server. To conﬁrm the deﬁned
peptides, the IEBD server was also used. Moreover, the high score
binding regions to HLA class II were selected by RANKPEP online
server.
3.4. Design and construction of multi-epitope peptide vaccine
The ﬁnal protein sequence was composed of 490 amino acids as
shown in Fig. 1. As the ﬁrst domain, HBHA was selected in the N
terminal of the construct as an adjuvant. As the second domain, four
regions from TTFrC (Table 2) and PADRE were applied as CD4+ helper
epitopes. The third domain was constructed by CTL and IFN-gamma
inducing epitopes selected from Hap1, LigA, LAg42, sphH and HSP58
protein sequences. Finally, proper linkers were used to make a linkage
between favorite peptide sequences. As mentioned above, to obtain
codon-optimized DNA sequence of the constructed protein, JCAT online
server was employed. JCAT contributes to optimized cloning and ex-
pression in E.coli as a host. High-level and optimum expression of chi-
meric sequence are more than 0.8 according to Codon adaptation index
(Schnoor et al., 2015). CAI in the adapted sequence was 0.97. GC-
Content of the improved sequence was also 51.63 % and GC-Content of
E. coli was 50.7. Graphical view of codon usage in optimized chimeric
gene was shown in Fig. 2.
3.5. mRNA structure prediction
Free energy related to whole mRNA structure and its 5′ end was
obtained using Mfold online service and its details are shown in Table 3.
The minimum free energy of secondary RNA structure was ΔG =
-529.00 kcal/mol without hairpin nor pseudoknot at 5′ side (Figs. 3 and
4).
3.6. Physico-chemical parameter, allergenicity, antigenicity and solubility
The molecular weight and theoretical isoelectric point value of the
chimeric protein were 53.476 kDa and 5.13, respectively. Extinction
coeﬃcients in units of M-1 cm-1 at 280 nm measured in water were
55030 and with absorption 0.1% (=1 g/l) 1.238, assuming all pairs of
Cys residues form cystines. The estimated half-life was reported
30 hours for mammalian reticulocytes in vitro,> 20 hours for yeast in
vivo, and> 10 hours for E. coli in vivo. The instability index (II) was
computed to be 27.37, thereby classifying the constructed protein as
stable. Aliphatic index and Grand average of hydropathicity (GRAVY)
were obtained to be 82.76 and -0.353, respectively. Obtained result
from ALgPred using the hybrid method indicated that the protein se-
quence did not contain experimentally proven IgE epitope and the
vaccine was non-allergen. In addition, antigenicity was also analyzed
and the overall prediction for antigenicity was reported 0.67 that sug-
gested the proposed multi-epitope molecule can be an appropriate an-
tigen. In contrast, human protein similarity was also assessed by per-
forming protein BLAST and its observation conﬁrms that there was the
lowest possible similarity between reported human proteins and pro-
posed vaccine molecule (Fig. 5). This observation assures that the de-
signed molecule will be recognized as foreign and immunogenic mo-
lecule, which will be capable to induce the humoral/cell mediated
immune response. In addition, the obtained results of epitope con-
servancy analysis showed the high similarity in other strains, and then
we can conclude that the epitopes which we have used for vaccine
designing will be capable to induce same immune response against all
pathogenic strains irrespective of their geographical distribution. Fur-
thermore, the constructed vaccine was soluble upon overexpression in
E. coli with probability of 0.99.
3.7. Secondary and tertiary structure prediction
The secondary structure of the protein that was predicted by
PSIPRED and GOR4 secondary structure prediction servers is composed
of 52.04 % alpha helix, 13.88% extended strand and 34.08% random
Table 1
Final IFN-γ and CTL epitopes selected from Hap1, LigA, LAg42, sphH and HSP58 antigens.
Selected
Antigen
Start
Position
End Position Sequence IFN epitope Identity Antigenicity score
Hap1 63 78 KPGQAPDGLVDGNKK + 100% 0.92
72 87 VDGNKKAYYLYVWIP + 100% 1.8
LigA 11 26 DNSNSDITDQVTWDS + 100% 0.49
18 33 TDQVTWDSSNTDILS + 100% 0.14
LAg42 54 69 QKLVVVGCFAERYPD + 100% 0.19
59 74 VGCFAERYPDNIHSE + 100% 0.61
sphH 19 34 KSLIGFYCLFMFFLN + 100% 1.80
28 43 FMFFLNCLPDKQKEH + 100% 0.90
HSP58 42 57 FGAPTITKDGVTVAK + 100% 0.74
69 84 AQMVKEVSTKTNDVA + 100% 0.96
Fig. 1. Schematic image of vaccine construct consists of
selected peptides from Hap1, LigA, LAg42, sphH and
HSP58 antigens, TTFrC and PADRE as helper epitopes and
HBHA as an adjuvant fused together by appropriate motifs
for expression in Escherichia coli.
Table 2
TTFrC MHC-II binding peptides determined by RANKPEP.
Epitope sequence Start position End position
NDIISDISGFNSSVITYPDAQLVPGINGKAIHLVNNE 40 66
IEYNDMFNNFTVSFWLRVPKVSASHLEQYGT 78 108
YVSIDKFRIFCKALNPKEIEKLYTSYLS 220 247
LRVGYNAPGIPLYKKMEAVKLRDLK 362 386
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coil as presented in Figs. 6 and 7. Using I-TASSER and Phyre2 services,
it was shown that there are three main domains in tertiary structure.
Phyre2 server indicated that 33% of residues were modelled at> 90%
accuracy.
3.8. Reﬁnement and validation of the 3D reﬁned structures
The obtained 3D structures were submitted for the reﬁnement
process by GalaxyReﬁne program. The GalaxyReﬁne server also in-
duced ﬁve 3D reﬁned models, which all entered the next step. The
qualities of the 3D structures were improved after reﬁnement according
to the results of the ProSA-web and Ramachandran Plot (Fig. 8). As
shown in Fig. 9, validation of protein 3D model by Ramachandran plot
before and after reﬁnement indicated that in initial model, 356
(73.0%), 62 (12.7%) and 70 (14.3%) of residues were located in fa-
vored, allowed and outlier regions, respectively. In the reﬁned model,
435 (89.1%), 39 (8.0%) and 14 (2.9%) of residues were located in fa-
vored, allowed and outlier regions, respectively.
3.9. Intrinsic disorder prediction
Disordered regions were identiﬁed and annotated by DisEMBL on-
line service. Amino acids in the input sequence are considered dis-
ordered by Loops/coils deﬁnition in the following regions: 41-71, 361-
381. Disordered regions were also shown in Fig. 10.
3.10. Prediction of B-cell epitopes
As mentioned in methods, the ﬁnal designed protein was applied to
the prediction of continuous and discontinuous B-cell epitopes by
BCPRED and Discotope 2.0 servers, respectively. Predicted linear B-cell
epitopes from full length constructed vaccine were shown in Table 4. In
addition, epitopes predicted in modeled vaccine based on diﬀerent
parameters of epitopes were shown in Table 5. Moreover, using
Fig. 2. Graphical view of codon usage in optimized chimeric gene.
Table 3
Free energy details related to 5’ end of chimeric gene mRNA structure by mfold
web server.
Structural element Free energy (kcal/
mol)
Base pair
External loop -1.80 17 ss bases & 2 closing helices.
Stack -0.90 External closing pair is U 603-A 1461
Stack -2.40 External closing pair is U 604-A 1460
Stack -3.30 External closing pair is C 605-G 1459
Helix -6.60 4 base pairs.
Fig. 3. Prediction of RNA secondary structure of chimeric gene by moﬂd server. Predicted structure has no hairpin and pseudo knot at 5′site of mRNA.
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DiscoTope 2.0 server, many conformational B-cell epitopes were iden-
tiﬁed in the ﬁnal 3D model.
3.11. Exploration of interaction between protein vaccine and TLR4
To evaluate the interaction of the designed vaccine and TLR4, mo-
lecular docking of the 3D models of these two proteins was done with
ClusPro 2.0. The docked models that represented interactions in mis-
allocated segments of either vaccine or TLR4 were excluded, and the
best docking model (shown in Fig. 11) was selected based on the re-
sidues involved in the interactions.
4. Discussion
Leptospirosis is a serious infection disease caused by pathogenic
strains of the Leptospira spirochetes, which aﬀects not only humans but
also animals (Adler et al., 2010). Although some leptospirosis vaccines
have been obtained, the vaccination is relatively unsuccessful in clinical
application despite decades of research (Wang et al., 2007). There are
two basic types of leptospirosis vaccines available, attenuated and in-
activated leptospirosis vaccines. However, these two types of vaccines
reveal signiﬁcant safety problems. Recombinant protein vaccines have
a great potential against leptospirosis (Koizumi and Watanabe, 2005;
Vinetz, 2001). Before production of recombinant protein vaccines
against leptospirosis for clinical application, extensive testing is
required. Recombinant protein vaccines must be stable and safe, and
have high immunogenicity, stability in various conditions, and high
speciﬁcity as well as aﬀordable production. Considering recent ad-
vances in the ﬁeld of vaccine development using bioinformatics and
immunoinformatics approaches, these issues seems resolvable in the
development of a vaccine against human leptospirosis (Karkhah and
Amani, 2016; Tourani et al., 2017). Therefore, in this study we devel-
oped a novel multi-epitope protein from immune-dominant peptides of
Hap1, LigA, LAg42, sphH and HSP58 antigens. For designing our
multivalent vaccine using immuno-informatics approaches, ﬁve regions
from these antigens were selected as T cell and IFN-gamma inducing
epitopes. Several lines of evidence introduced IFN-gamma as the sig-
nature cytokine of both the innate and adaptive immune system eli-
citing antiviral, immune regulatory as well as anti-tumor activities. The
release of IFN-gamma is the major arm of the Th1 response critical for
the control of pathogens such as leptospirosis (Schoenborn and Wilson,
2007). Moreover, to induce strong CD4+ helper T lymphocytes (HTLs)
responses, four regions of TTFrC along with Pan HLA DR-binding epi-
tope (PADRE) were deﬁned as helper epitopes. A key feature of this
universally immunogenic epitopes is its capacity to bind to several
isotypic and allotypic forms of human MHC class II molecules inducing
an increased and long term immune response by increasing the helper
T-cell response (Panina-Bordignon et al., 1989). It has been reported
that leptospirosis vaccines with adjuvant are more immunogenic than
those without adjuvant (Fraser et al., 2007). Therefore, Heparin-
Fig. 4. Circle graph structure. A circle graph is one way to display base pairs of a structure. It also represents a ﬁrst step to producing a formal structure in which
overlap of bases is usually small.
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Binding Hemagglutinin (HBHA), a novel TLR4 agonist was added to the
construct as an adjuvant. The ﬁnal vaccine consisted of three domains:
HBHA as an adjuvant, helper epitopes (TTFrC and PADRE) and anti-
genic epitopes. GPGPG, AAY and HEYGAEALERAG cleavable linkers
were used to separate these three domains from each other in order to
enhance epitope presentation. These linkers have dual roles in epitope
vaccine structure; ﬁrst, preventing the generation of junctional epitopes
(neoepitopes) that is the important concern in designing epitope vac-
cines, and second, facilitating the immune processing and presentation
of HLA-II binding epitopes (Livingston et al., 2002; Meza et al., 2017;
Nezafat et al., 2016). In addition, because of functional features of
HBHA, as TLR4 agonist, the EAAAK linker was used to link HBHA to N
terminal of vaccine construct as an adjuvant to reduce the interaction
with other vaccine sections and cause more eﬀective separation (Arai
et al., 2001). In addition, it should be noted that there are some in-
vestigations demonstrated that GPGPG spacer construct can be used to
induce HTL responses by either polypeptide or DNA immunization to
control infection (Livingston et al., 2002). Because the induction of Th
lymphocytes are a crucial component of both the humoral and cellular
immune response and also the secretion of cytokines by HTL is im-
portant in the diﬀerentiation of CTL (Chaplin, 2010); hence, these im-
mune-dominant epitopes and linkers were used in our multi- epitope
construct.
Therefore, a multi-epitope vaccine was constructed with 490 re-
sidues in length. Restriction sites, instability elements, and all the cis-
acting sites were removed from the construct which signiﬁcantly in-
terfering with cloning. In addition, codon optimization was performed
to improve transcriptional and translational eﬃciency and to facilitate
Fig. 5. Multiple sequence alignment between multi-epitope proposed vaccine and human proteins showed the lowest possible similarity.
Fig. 6. GOR IV server results indicated that constructed vaccine includes 52.04%alpha helix (H), 13.88% extended strand and 34.08% random coil (C) in secondary
structure.
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high-level expression of recombinant protein vaccine in E. coli. mRNA
secondary structure is a signiﬁcant factor in expression of proteins. The
results from mRNA prediction by Mfold server indicated that the mRNA
had enough stability for eﬀective translation in the host. Higher stabi-
lity consequently leads to higher expression rate.
Physico-chemical parameters analysis by ProtParam software in-
dicated that estimated half-life of predicted vaccine was 30 hours in
mammalian reticulocytes, more than 20 hours in yeast and more than
10 hours in E. coli. In addition, Expasy ProtParam classiﬁes the chi-
meric protein as stable protein with instability index, 27.37.
Furthermore, the tendency of vaccine solubility upon overexpression in
E. coli was calculated 0.99% showing an acceptable percentage of so-
lubility in an overexpressed state.
Phyre2 program was used to generate the initial 3D structure of
protein vaccine. Obtained results showed that, 33% of residues mod-
elled at> 90% conﬁdence. The evaluation of the initial model with
Ramachandran plot showed that the model requires the reﬁnement
process. The reﬁnement of modeled structure was carried out in
GalaxyReﬁne server by molecular dynamics simulation. Ramachandran
plot assessment after reﬁnement showed reﬁnement applying
GalaxyReﬁne server resulted in modeling of a high-quality 3D model.
The analysis of all continuous and discontinuous B-cell epitopes de-
monstrated that the identiﬁed epitopes on protein surface could interact
easily with antibodies, and they were generally ﬂexible.
To determine disorder and unstructured regions in the constructed
vaccine diﬀerent server including DisEMBL 1.5, IUPred and DISOP-
RED3 were used. Obtained results demonstrated that disorder regions
were placed between positions 41-71, 361-381. An intrinsically dis-
ordered protein (IDP) is classically deﬁned as a protein with lacking a
ﬁxed or well-structured three-dimensional fold. IDPs include a spec-
trum of states from fully unstructured to partially structured and in-
clude random coils, (pre-) molten globules, and large multi-domain
proteins connected by ﬂexible linkers. Disordered regions are often
functional. Many disordered segments fold on binding to their biolo-
gical targets and some others constitute ﬂexible linkers leading to
Fig. 7. Graphical result from secondary structure prediction of vaccine using PSIPRED.
Fig. 8. Reﬁned modeled structure of constructed vaccine using Phyre2 soft-
ware.
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assembly of macromolecular array (Dunker et al., 2001).
Taken together, however computational approaches are important
step and tools for assessment of the vaccines before initiating the
experimental study, constructed vaccine using these immunoinfor-
matics methods should be experimentally evaluated to clarify eﬃciency
and success of ﬁnal designed vaccine. Therefore, to complete our study
on epitope based vaccine development against leptospirosis, it can be
suggested in vitro synthesis and in vivo experimental studies to assess
the diﬀerent physical and chemical aspect of this multi-epitope vaccine.
5. Conclusion
In the present study, we design a multi-epitope vaccine candidate
based on epitopes of Hap1, LigA, LAg42, SphH and HSP58 antigens
employing computational servers. Immunoinformatics analyses in-
dicated that this vaccine is a qualiﬁed candidate for immune response
reinforcement against leptospirosis by inducing IFN-gamma produc-
tion. Thus, this multi-epitope vaccine can possibly be utilized for pro-
phylactic or therapeutic usages.
Fig. 9. Validation of protein 3D model, before and after reﬁnement by Ramachandran plot. (a) In initial model, 356 (73.0%), 62 (12.7%) and 70 (14.3%) of residues
were located in favored, allowed and outlier regions, respectively. (b) In reﬁned model, in reﬁned model, 435 (89.1%), 39 (8.0%) and 14 (2.9%) of residues were
located in favored, allowed and outlier regions, respectively.
Fig. 10. Intrinsically disorder regions. Amino acids in the input sequence were considered disordered when the red line is above the grey dashed line, that is the
conﬁdence score is higher than 0.5.
Table 4
Linear B-Cell epitopes from full length constructed vaccine by using Bcepred.
Position Epitope Score
259 QYGTGPGPGLRVGYNAPGIP 1
181 KAAAGPGPGNDIISDISGFN 1
216 NGKAIHLVNNEGPGPGIEYN 1
288 LRDLKGPGPGYVSIDKFRIF 0.999
42 RERAEETRTDTRSRVEESRA 0.996
325 SAAYKPGQAPDGLVDGNKKA 0.98
365 DNSNSDITDQVTWDSSNTDI 0.973
464 AQMVKEVSTKTNDVAHEYGA 0.964
400 KLVVVGCFAERYPDNIHSEA 0.954
439 PDKQKEHAAYFGAPTITKDG 0.943
63 LTKLQEDLPEQLTELREKFT 0.745
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